Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 10, 2007
Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group, Sharon D Solomon, Joan L Jefferys, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 31, 2017
Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyesYannis M Paulus, Joan L Jefferys, Barbara S Hawkins, et al.
Retina (Philadelphia, Pa.)|February 10, 2007
Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history studyJanet S Sunness, Carol A Applegate, Neil M Bressler, et al.
JAMA Ophthalmology|August 30, 2019
Outcome Specification in a Sample of Publicly Funded Eye and Vision Trials Registered on ClinicalTrials.govJimmy T Le, Kai Sheng, Ian J Saldanha, et al.
The Cochrane Database of Systematic Reviews|August 30, 2014
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationSharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, et al.
The Cochrane Database of Systematic Reviews|March 25, 2021
Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconusSueko M Ng, Mark Ren, Kristina B Lindsley, et al.
Ophthalmology|June 19, 2007
Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: Submacular Surgery Trials Report No. 18, Ashley L Mann, Susan B Bressler, et al.
The Cochrane Database of Systematic Reviews|March 6, 2019
Anti-vascular endothelial growth factor for neovascular age-related macular degenerationSharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, et al.
Retina (Philadelphia, Pa.)|December 11, 2012
Current knowledge and trends in age-related macular degeneration: today's and future treatmentsRaul Velez-Montoya, Scott C N Oliver, Jeffrey L Olson, et al.
The New England Journal of Medicine|April 30, 2011
Ranibizumab and bevacizumab for neovascular age-related macular degeneration, Daniel F Martin, Maureen G Maguire, et al.
Pageof 8